J 508

Known as: J-508 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-2014
01219782014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND (-)-Deprenyl and rasagiline are classified as selective inhibitors of B-type MAO. The DATATOP study revealed that the… (More)
Is this relevant?
2008
2008
N-methylpropargylamine-1-aminoindane (J-508), a strong releaser of catecholamines was described 30 years ago as a more potent… (More)
Is this relevant?
2000
2000
The noradrenaline (NA), dopamine (DA) and serotonin (5HT) reuptake inhibitory potency of deprenyl, the highly selective and… (More)
Is this relevant?
1989
1989
The concentrations of monoamine oxidase-A and -B were determined in homogenates of human cerebral cortex, caudatus and placenta… (More)
Is this relevant?
1986
1986
The concentrations of monoamine oxidase-A and -B have been determined in mitochondria, mitochondrial outer membranes and… (More)
Is this relevant?
1986
1986
Phenylethylamine (PEA) in a dose of 40 mg/kg induces a moderate and short-lasting stereotype behaviour. The intensity and… (More)
Is this relevant?
1982
1982
The effects of single doses of (-)deprenyl, in comparison to J-508, U-1424, pargyline and clorgyline, on the sexual performance… (More)
Is this relevant?
1980
1980
The interaction of the substrate-selective irreversible inhibitor J-508 [N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
  • figure 4
Is this relevant?
1979
1979
The interaction between rat brain monoamine oxidase-B and J-508, an analogue of L-deprenil, has been investigated. J-508 inhibits… (More)
Is this relevant?
1978
1978
(-)Deprenyl, a selective inhibitor of MAO-B, was found to be 60 times less potent in inhibiting intestinal MAO in the rat than… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 3
Is this relevant?